Skip to main content

Advertisement

Table 1 The scaffold modifications used in this study

From: Argon plasma surface modification promotes the therapeutic angiogenesis and tissue formation of tissue-engineered scaffolds in vivo by adipose-derived stem cells

Scaffold Group Number Scaffold Type Scaffolds Modification Technique Abbreviation
1 Control Scaffolds Polyurethane nanocomposite scaffolds without modification PU
2 Scaffold modified with ADSCs Polyurethane nanocomposite scaffolds modified with 1 x 106 cells per scaffold. ADSCs seeded on the scaffold for 24 hours prior to implantation. ADSC
3 Scaffold modified with PRP Scaffold modified with PRP at a concentration of 20.2 x 104/ml with a 30 minute incubation time prior to implantation. PRP
4 Scaffolds modified with plasma surface modification Scaffold modified with argon plasma surface modification for 5 minutes immediately prior to implantation. PM
5 Scaffolds modified with plasma surface modification + ADSC Scaffolds modified as per group 2 and 4. PM + ADSC
6 Scaffolds modified with plasma surface modification + PRP. Scaffolds modified as per group 3 and 4. PM + PRP
7 Scaffolds modified with ADSC + PRP. Scaffold modified with 2 + 3. ADSC + PRP
8 Scaffolds modified with plasma surface modification + PRP + ADSC Scaffolds modified as per group 2 and 3 and 4. PM + PRP + ADSC